Showing all published months. Partner preview tables include up to 5 countries.
USD value by month, all available partner countries combined
Free partner preview shows up to 5 countries.
Total value across the selected data period
| Partner | Value | Share |
|---|---|---|
| India | $831.4M | 29.6% |
| United States | $282M | 10.0% |
| Japan | $250M | 8.9% |
| Brazil | $141.5M | 5.0% |
| Hong Kong | $104.8M | 3.7% |
Availability is confirmed when the API response loads.
| Partner | Value | Share |
|---|---|---|
| Japan | $8.9M | 29.8% |
| India | $4.6M | 15.6% |
| United States | $2.9M | 9.8% |
| Colombia | $1.8M | 6.2% |
| Bangladesh | $1.2M | 4.2% |
| Year | Export value |
|---|---|
| 2021 | $392.2M |
| 2022 | $513.3M |
| 2023 | $494M |
| 2024 | $543.8M |
| 2025 | $519M |
| 2026 | $345.3M |
China customs reports HS 300390 at the 8-digit level. 1 subheading is published under it, and export values for each are available on request.
Public data shows up to 5 partner countries. Request all available countries, years, quantity fields, or HS8 detail in CSV.
HS 300390 is also written 3003.90. Values are in USD; the public series does not report tonnes or kg. Product scope: Bulk mixed medicinal preparations for therapeutic or preventative uses, supplied without measured doses or retail packaging, excluding pure hormones, antibiotics, and specific blood or vaccine products. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Medicaments consisting of two (HS 300390) Export Data." https://chinadata.live/china-trade/hs/300390/
HS 300390 is also written 3003.90. Values are in USD; the public series does not report tonnes or kg. Product scope: Bulk mixed medicinal preparations for therapeutic or preventative uses, supplied without measured doses or retail packaging, excluding pure hormones, antibiotics, and specific blood or vaccine products. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Medicaments consisting of two (HS 300390) Export Data." https://chinadata.live/china-trade/hs/300390/
China exported $526M of medicaments consisting of two in the twelve months to August 2026, averaging $43.9M per month, based on official China customs statistics (HS 300390).
Bulk mixed medicinal preparations for therapeutic or preventative uses, supplied without measured doses or retail packaging, excluding pure hormones, antibiotics, and specific blood or vaccine products.
India, United States and Japan together account for 49% of the published total, out of 73 trading partners on record.
Annual exports grew by 32% between 2021 and 2025, from $392M to $519M.
Figures come from official China General Administration of Customs (GACC) statistics, published monthly. ChinaData cleans partner names, periods and values so the series is ready for analysis. Partner-level rows for every month, including HS8 detail, are available on request.